Developer docs
API playgroundTry for free, no card

Search company profiles

Biofarm

Full company profile

uuid000ethw

Namestring
Biofarm
Legal namestring
Biofarm Sp. z o.o.
Websiteurl
biofarm.pl
Company typeenum
Private
Founded yearint
1988
Descriptiontext

Biofarm Sp. z o.o. is a privately held, family-owned Polish pharmaceutical manufacturer founded in 1988 and headquartered in Poznań. The company operates a single EU GMP-certified production facility supported by an in-house Research & Development Centre, producing prescription (RX) medicines, over-the-counter (OTC) drugs, dietary supplements, and cosmetics. Its therapeutic focus spans neurology, cardiology, psychiatry, and internal medicine, with a portfolio of over 180 registered products, of which approximately 80% are developed in-house and 13 are protected by patent applications covering innovative formulations. Biofarm has established multiple first-in-Poland and first-in-Europe launches, including Atrox (atorvastatin, 2007), Bioprazol Bio (first Polish OTC omeprazole, 2009), Biomentin (first European memantine generic, 2012), Tamivil (patented Polish oseltamivir, 2018), Proaxon (first Polish cyticoline, 2018), and Solcidiol (first Polish calcifediol, 2019).

The business model is B2B-led, distributing through wholesalers and pharmacies in Poland, supported by a dedicated export department selling to 37 countries across four continents. Biofarm employs over 450 people, has invested more than 100 million PLN in R&D and modernised production equipment over 13 years, and expanded its production footprint by over 450 m² between 2018 and 2020. In 2025, the company received the Eurasian Union GMP certificate, complementing its longstanding EU GMP certification, and reached a production milestone of over 1 million 75 mg packages of Tamivil. Ownership remains 100% with the Szwarczyński family, with no public listing, no external investors, and no disclosed revenue. The company is funded by reinvested earnings, EU research grants totalling approximately 30 million PLN across 16 contests, and a PLN 6,000,000 share capital base.

Short descriptiontext

Biofarm is a family-owned Polish pharmaceutical manufacturer producing prescription medicines, OTC drugs, and dietary supplements in neurology, cardiology, psychiatry, and internal medicine. Operating from a single EU GMP-certified facility in Poznań, the company exports to 37 countries across four continents.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersPoznan, Poland
HQ citystring
Poznan
HQ countrystring
Poland
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
generic pharmaceuticals, prescription medicines, OTC drugs, dietary supplements, contract manufacturing
Industry5 codes
PRIMARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIACAG
Cardiology & Vascular Specialty Pharmaceuticals
SECONDARYHLAIAAAA
Primary Care & General Medicine Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIABAL
Generic Hospital & Institutional Products
SECONDARYCRADAGAG
Weight Management & Metabolic Supplements
NAICS code4 codes
  • Pharmaceutical and Medicine Manufacturing3254
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
  • Pharmaceutical Preparation Manufacturing325412
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Generic Pharmaceuticals Manufacturing
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model4 records
1Pharmaceutical product sales (RX prescription medicines)
TypeOne Time License
Description

Sales of prescription medicines (RX) covering cardiology, neurology, psychiatry and internal medicine therapeutic areas. Products include Nebicard (nebivolol), Pantopraz (pantoprazol), Metoprolol Biofarm ZK, Biomentin (memantine), Vicebrol (vinpocetine), Atrox (atorvastatin), Artigo (cinnarizine+dimenhydrinate), Aciprex (escitalopram), Asertin (sertraline), Amertil (cetirizine), Sedival, Tamivil, Noctis, Diured, Liprox, Losacor, Losacor HCT, Betanil Forte, Triacyt MR, Pulsaren, Theospirex retard, Proaxon, Aspicam (meloxicam), Lapixen, Tiocolis, Solcidiol, Folifem. Sold through wholesalers and pharmacies in Poland and export markets.

biofarm.pl
2OTC drug sales (over-the-counter)
TypeOne Time License
Description

Sales of OTC medicines including Vigalex vitamin D3 (1000, 2000, 4000 IU), Magnefar B6 Forte and Magnefar B6 Bio (magnesium + B6), Biotynox/Biotynox Forte (biotin), Ginkofar line (ginkgo biloba leaf dry extract 40/80/120/240 mg), Tribux Bio (trimebutine), Amertil Bio, Halset, Bioprazol Bio Max. Sold via pharmacy retail channel.

biofarm.pl
3Dietary supplements sales
TypeOne Time License
Description

Sales of dietary supplements including Vigalex D3+K2, Magnefar B6 Cardio, Prewenit Balance D, Prewenit Intensiv B, Neurotynox D, Artrostav Complex D3, Cemax Forte, Cemax, Sinusal Extra. Distributed via pharmacy and retail channels.

biofarm.pl
4Export sales (international)
TypeTransaction Fee
Description

Export of pharmaceutical products to international markets; commenced in 2002. Rosuvastatin was launched in 17 countries in 2022; Tamivil positioned as a leader with over 1 million packages produced in 2025. Biofarm products present in 37 countries on 4 continents as of 2025. Managed by dedicated Export Department (export@biofarm.pl).

biofarm.pl
Cost components6 values
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Pricing details1 tier
1Quote-based B2B pharmaceutical pricing
ModelOtherBilling cadenceAnnual
Notes

No public price list; pricing handled through wholesale and export distribution channels. Share Capital: PLN 6,000,000.00 disclosed in legal note.

biofarm.pl
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 31 records shown
1Ginkofar
Description

OTC/RX line based on Ginkgo biloba extract (40mg, 80mg, 120mg, 240mg doses)

biofarm.pl
+30 more records
Core offering1 text field

Biofarm manufactures and supplies a portfolio of 180+ registered pharmaceutical products across prescription (RX) medicines, over-the-counter (OTC) drugs, dietary supplements, and cosmetics, with ~80% of formulations developed in-house. The portfolio spans cardiology, neurology, psychiatry and internal medicine therapeutic areas and is sold through wholesalers and pharmacies in Poland and exported to 37 countries on four continents, with key innovations including first-in-Poland launches of atorvastatin, OTC omeprazole, memantine, oseltamivir, and vitamin D3 lines.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Biofarm Sp. z o.o. operates a single integrated pharmaceutical manufacturing business (no SaaS platform) organized around three core product categories developed and produced at its EU GMP-certified facility in Poznań, Poland: (1) RX (prescription) medicines spanning cardiology, neurology, psychiatry, and internal medicine — including flagship products such as Nebicard (nebivolol), Pantopraz (pantoprazole), Atrox (atorvastatin), Biomentin (memantine), Vicebrol (vinpocetine), Tamivil (oseltamivir), Proaxon (citicoline), Artigo (cinnarizine+dimenhydrinate), Asertin (sertraline), Aciprex (escitalopram), Metoprolol Biofarm ZK (metoprolol succinate), Amertil (cetirizine), and Aspicam (meloxicam); (2) OTC drugs including the memory-support Ginkofar line (40/80/120/240 mg Ginkgo biloba), Bioprazol Bio Max (OTC omeprazole), the Vigalex vitamin D3 line (1000/2000/4000 IU), Magnefar B6 Forte / Magnefar B6 Bio, Biotynox / Biotynox Forte (biotin), Noctis Noc (doxylamine sleep aid), and Trymigan (OTC trimebutine); and (3) dietary supplements such as Vigalex D3+K2, Magnefar B6 Cardio, Prewenit Balance D, Prewenit Intensiv B, Neurotynox D, Artrostav Complex D3, Cemax / Cemax Forte, and Sinusal Extra. Approximately 80% of the portfolio is developed in-house at Biofarm's R&D Centre, and the company holds 13 patent applications covering innovative formulations in oncology, cardiology, psychiatry, and internal medicine. Products are exported to 37 countries across four continents, with key first-in-Poland innovations including Atrox (2007), Bioprazol Bio (2009), Biomentin (2012), Lapixen (2014), Ginkofar Extra (2015), Tribux Bio (2016), Proaxon (2018), Tamivil (2018), Tiocolis (2018), Noctis (2019), Artigo (2019), Nebicard 10 mg (2019), Biotynox Forte (2019), and Solcidiol (2019).

Product and service44 records
1Atrox (Atorvastatin 10/20/40/80 mg)
CategoryRX prescription medicine
Description

Atorvastatin tablets (10–80 mg) for hypercholesterolaemia and prevention of cardiovascular events; the first Polish atorvastatin (launched 2007); sold as RX prescription medicine via wholesalers and pharmacies.

2Biomentin (Memantine 10/20 mg)
CategoryRX prescription medicine
Description

Memantine hydrochloride tablets (10/20 mg) for moderate-to-severe Alzheimer's disease; the first memantine generic in Europe (launched 2012); sold as RX prescription medicine.

3Tamivil (Oseltamivir 75 mg)
CategoryRX prescription medicine
Description

Patented small-tablet oseltamivir formulation (75 mg) for influenza treatment; the first Polish oseltamivir (launched 2018) and a Biofarm production leader with 1M+ packages produced in 2025; sold as RX prescription medicine.

4Proaxon (Citicoline)
CategoryRX prescription medicine
Description

Cyticoline-based neurology medicine; the first and only cyticoline-containing medicine in Poland (launched 2018); sold as RX prescription medicine.

5Nebicard 10 mg (Nebivolol)
CategoryRX prescription medicine
Description

Nebivolol 10 mg beta-blocker for essential hypertension, chronic stable heart failure, and symptomatic stable coronary artery disease; the first nebivolol 10 mg in Poland (launched 2019); sold as RX prescription medicine.

6Pantopraz 20/40 mg (Pantoprazole)
CategoryRX prescription medicine
Description

Pantoprazole 20/40 mg enteric-coated tablets for reflux oesophagitis, H. pylori eradication, gastric/duodenal ulcer, and Zollinger-Ellison syndrome; sold as RX prescription medicine.

7Vicebrol / Vicebrol Forte (Vinpocetine 5/10 mg)
CategoryRX prescription medicine
Description

Vinpocetine 5/10 mg tablets for chronic cerebral circulatory insufficiency, vascular dementia, and adjunctive treatment of choroidal/retinal circulatory disorders; sold as RX prescription medicine.

8Aciprex (Escitalopram 10/20 mg)
CategoryRX prescription medicine
Description

Escitalopram 10/20 mg SSRI for major depressive episodes, panic disorder, social phobia, OCD, and generalized anxiety disorder; sold as RX prescription medicine.

9Asertin 50/100 mg (Sertraline)
CategoryRX prescription medicine
Description

Sertraline 50/100 mg SSRI for major depression, panic disorder, OCD, social anxiety disorder, and PTSD; sold as RX prescription medicine.

10Metoprolol Biofarm ZK 23.75/47.5 mg
CategoryRX prescription medicine
Description

Metoprolol succinate extended-release 23.75/47.5 mg for hypertension, angina, cardiac arrhythmias, post-MI prophylaxis, migraine prophylaxis, and stable symptomatic heart failure; sold as RX prescription medicine.

11Artigo (Cinnarizine 20 mg + Dimenhydrinate 40 mg)
CategoryRX prescription medicine
Description

Cinnarizine 20 mg + dimenhydrinate 40 mg tablets for treatment of vertigo symptoms of various origins; the first generic of this combination in Poland (launched 2019); sold as RX prescription medicine.

12Aspicam 15 mg (Meloxicam)
CategoryRX prescription medicine
Description

Meloxicam 15 mg NSAID for symptomatic treatment of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis; sold as RX prescription medicine.

13Lapixen (Lacidipine)
CategoryRX prescription medicine
Description

Lacidipine antihypertensive; the first lacidipine generic drug in Poland (launched 2014); sold as RX prescription medicine.

14Tiocolis (Thiocolchicoside)
CategoryRX prescription medicine
Description

Thiocolchicoside muscle relaxant; the first and only thiocolchicoside-based medicine in Poland (launched 2018); sold as RX prescription medicine.

15Solcidiol (Calcifediol)
CategoryRX prescription medicine
Description

Calcifediol vitamin D metabolite supplement product; the first calcifediol product in Poland (launched 2019); sold as RX prescription medicine.

16Sedival (RX)
CategoryRX prescription medicine
Description

RX medicine in Biofarm's neurology/internal medicine portfolio; sold as RX prescription medicine via wholesalers and pharmacies.

17Diured (RX)
CategoryRX prescription medicine
Description

RX diuretic in Biofarm's cardiovascular portfolio; sold as RX prescription medicine.

18Losacor / Losacor HCT (Losartan ± HCTZ)
CategoryRX prescription medicine
Description

Losartan and losartan + hydrochlorothiazide combination antihypertensive medicines in Biofarm's RX portfolio; sold as RX prescription medicine.

19Betanil Forte (RX)
CategoryRX prescription medicine
Description

RX cardiovascular medicine in Biofarm's RX portfolio; sold as RX prescription medicine.

20Triacyt MR (RX)
CategoryRX prescription medicine
Description

Modified-release RX cardiovascular preparation in Biofarm's RX portfolio; sold as RX prescription medicine.

21Pulsaren 10/20 (RX)
CategoryRX prescription medicine
Description

RX cardiovascular medicine in Biofarm's RX portfolio; sold as RX prescription medicine.

22Theospirex retard 150/300 mg
CategoryRX prescription medicine
Description

Theophylline prolonged-release bronchodilator (150/300 mg); Theospirex retard 300 mg was Biofarm's first drug in production (1991); sold as RX prescription medicine.

23Amertil (Cetirizine 10 mg)
CategoryRX prescription medicine
Description

Cetirizine hydrochloride 10 mg antihistamine for seasonal/perennial allergic rhinosinusitis and chronic idiopathic urticaria; sold as RX prescription medicine.

24Noctis (Doxylamine)
CategoryRX prescription medicine
Description

Doxylamine-based nighttime sleep-support medicine; the first doxylamine-based product in Poland (launched 2019); sold as RX prescription medicine.

25Ginkofar (Ginkgo biloba 40/80/120 mg)
CategoryOTC drug
Description

Ginkgo biloba leaf dry extract tablets (40/80/120 mg) supporting memory and cognitive function; Biofarm's first in-house developed product (1996); sold as OTC drug via pharmacies.

26Ginkofar Extra (Ginkgo biloba 240 mg)
CategoryOTC drug
Description

High-dose Ginkgo biloba leaf dry extract 240 mg tablet; the first and only 240 mg Ginkgo Biloba dose in Poland (launched 2015); sold as OTC drug via pharmacies.

27Bioprazol Bio Max (Omeprazole OTC)
CategoryOTC drug
Description

OTC omeprazole for gastric reflux; Bioprazol Bio (2009) was the first omeprazole available without prescription in Poland; sold as OTC drug via pharmacies.

28Vigalex (Vitamin D3 1000/2000/4000 IU line)
CategoryOTC drug
Description

Vitamin D3 OTC line in 1000/2000/4000 IU dose strengths supporting immunity and bone health; launched in 2020 (Vigalex Bio, Forte, Max) establishing Biofarm as a Vitamin D3 expert; sold as OTC drug via pharmacies.

29Magnefar B6 Forte / Magnefar B6 Bio
CategoryOTC drug
Description

Magnesium + Vitamin B6 combinations in higher-dose (Magnefar B6 Forte) and standard (Magnefar B6 Bio) variants for fatigue, cramps and magnesium deficiency symptoms; launched as OTC in 2019; sold via pharmacy retail channel.

30Biotynox / Biotynox Forte (Biotin 5/10 mg)
CategoryOTC drug
Description

Biotin (vitamin B7) tablets in 5 mg and 10 mg strengths; Biotynox Forte (2019) was the first drug in Poland with the highest 10 mg biotin dose; sold as OTC drug via pharmacies.

31Trymigan (OTC Trimebutine)
CategoryOTC drug
Description

OTC trimebutine product for abdominal/GI symptom relief; Tribux Bio (2016) was the first OTC trimebutine in Europe; sold as OTC drug via pharmacies.

32Noctis Noc (OTC Sleep Aid)
CategoryOTC drug
Description

Nighttime sleep-support OTC product based on doxylamine; sold via pharmacy retail channel.

33Melatonina (OTC)
CategoryOTC drug
Description

Melatonin-based OTC sleep and circadian rhythm support product; sold via pharmacy retail channel.

34Amertil Bio (OTC Cetirizine)
CategoryOTC drug
Description

OTC cetirizine-based antihistamine for allergic rhinitis and chronic idiopathic urticaria; sold via pharmacy retail channel.

35Soyfem (Soy Isoflavones)
CategoryOTC drug / supplement
Description

Soy isoflavone OTC/supplement for menopausal symptom relief; multiple-time 'Product of the Year' in its category (2005-2011); sold via pharmacy and retail channels.

36Vigalex D3+K2 (Dietary Supplement)
CategoryDietary supplement
Description

Dietary supplement combining Vitamin D3 with Vitamin K2 to support bone health; distributed via pharmacy and retail channels.

37Magnefar B6 Cardio (Dietary Supplement)
CategoryDietary supplement
Description

Magnesium + Vitamin B6 dietary supplement positioned for cardiovascular support; distributed via pharmacy and retail channels.

38Prewenit Balance D (Dietary Supplement)
CategoryDietary supplement
Description

Dietary supplement in Biofarm's Prewenit line supporting micronutrient balance with Vitamin D; distributed via pharmacy and retail channels.

39Prewenit Intensiv B (Dietary Supplement)
CategoryDietary supplement
Description

Dietary supplement in Biofarm's Prewenit line with intensified B-vitamin composition; distributed via pharmacy and retail channels.

40Neurotynox D (Dietary Supplement)
CategoryDietary supplement
Description

Dietary supplement combining neurotropic vitamins and Vitamin D for nervous-system support; distributed via pharmacy and retail channels.

41Artrostav Complex D3 (Dietary Supplement)
CategoryDietary supplement
Description

Joint-and-bone dietary supplement with Vitamin D3; distributed via pharmacy and retail channels.

42Cemax / Cemax Forte (Vitamin C Dietary Supplements)
CategoryDietary supplement
Description

Vitamin C dietary supplements in regular and Forte dose; distributed via pharmacy and retail channels.

43Sinusal Extra (Dietary Supplement)
CategoryDietary supplement
Description

Dietary supplement supporting sinus and upper respiratory tract health; distributed via pharmacy and retail channels.

44Biofarm Cosmetics Line
CategoryCosmetics
Description

Pharmaceutical-grade cosmetics product line manufactured at the Poznań facility; sold via pharmacy and retail channels.

Recent move11 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Poland's largest pharmaceutical manufacturer and the most direct domestic peer. Operates a similar generics-plus-OTC model with Rx focus on cardiology, neurology and internal medicine, and exports to CEE/CIS markets — directly overlapping with Biofarm's product, channel and geographic footprint.

TypeDirect peer
Description

Polish family-owned pharma company with parallel portfolio strategy: in-house developed generics in cardiology, neurology and psychiatry, plus OTC and dietary supplements, with growing CEE export presence. Closely comparable in therapeutic mix, ownership structure and Polish-CEE GTM motion.

TypeDirect peer
Description

Slovenian-headquartered generic pharmaceutical manufacturer with a broad Rx portfolio in cardiology, neurology and psychiatry and a multi-continent export footprint including strong CEE/CIS coverage. Comparable in generics-first business model, vertical manufacturing, and emerging-market expansion playbook.

TypeDirect peer
Description

Hungarian pharmaceutical company with a generic-heavy portfolio across CNS, cardiology and women's health, plus OTC/supplement extensions, and an export footprint spanning CEE, CIS and Western Europe. Highly comparable therapeutic focus and CEE-centric GTM.

TypeDirect peer
Description

European generic and OTC pharmaceutical manufacturer headquartered in Prague with broad pan-European presence. Operates the same generics-plus-OTC-plus-supplement model in cardiology, neurology and internal medicine, with comparable reliance on European reimbursement systems.

TypeBroad incumbent
Description

World's largest generic drug manufacturer with a broad generics, specialty and OTC portfolio. Competes with Biofarm across multiple molecules (e.g., memantine, atorvastatin, nebivolol, omeprazole) but at vastly larger scale and global reach.

7Sandoz
TypeBroad incumbent
Description

Novartis's generics and biosimilars division; one of the world's largest manufacturers of off-patent medicines including antibiotics, cardiovascular and CNS generics. Competes with Biofarm on global tender pricing across overlapping molecules.

TypeBroad incumbent
Description

German generics, specialty and consumer healthcare company with strong European distribution and CEE presence. Overlaps with Biofarm in generics, OTC and dietary supplements, particularly through its Central European footprint.

TypeBroad incumbent
Description

Global healthcare company formed from the Mylan-Upjohn merger; offers a broad portfolio of generics, branded and OTC products worldwide, including cardiology and CNS molecules overlapping with Biofarm's Rx portfolio.

TypeEmerging player
Description

US-headquartered but with significant Central and Eastern European operations (including Alvogen CEE), focused on generics, biosimilars and OTC across emerging markets. Comparable to Biofarm in CEE export-led generics strategy, though broader in biosimilars.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Biofarm

Generic Pharmaceuticals Manufacturingbiofarm.pl

Biofarm is a family-owned Polish pharmaceutical manufacturer producing prescription medicines, OTC drugs, and dietary supplements in neurology, cardiology, psychiatry, and internal medicine. Operating from a single EU GMP-certified facility in Poznań, the company exports to 37 countries across four continents.

What Biofarm does

Biofarm Sp. z o.o. is a privately held, family-owned Polish pharmaceutical manufacturer founded in 1988 and headquartered in Poznań. The company operates a single EU GMP-certified production facility supported by an in-house Research & Development Centre, producing prescription (RX) medicines, over-the-counter (OTC) drugs, dietary supplements, and cosmetics. Its therapeutic focus spans neurology, cardiology, psychiatry, and internal medicine, with a portfolio of over 180 registered products, of which approximately 80% are developed in-house and 13 are protected by patent applications covering innovative formulations. Biofarm has established multiple first-in-Poland and first-in-Europe launches, including Atrox (atorvastatin, 2007), Bioprazol Bio (first Polish OTC omeprazole, 2009), Biomentin (first European memantine generic, 2012), Tamivil (patented Polish oseltamivir, 2018), Proaxon (first Polish cyticoline, 2018), and Solcidiol (first Polish calcifediol, 2019).

The business model is B2B-led, distributing through wholesalers and pharmacies in Poland, supported by a dedicated export department selling to 37 countries across four continents. Biofarm employs over 450 people, has invested more than 100 million PLN in R&D and modernised production equipment over 13 years, and expanded its production footprint by over 450 m² between 2018 and 2020. In 2025, the company received the Eurasian Union GMP certificate, complementing its longstanding EU GMP certification, and reached a production milestone of over 1 million 75 mg packages of Tamivil. Ownership remains 100% with the Szwarczyński family, with no public listing, no external investors, and no disclosed revenue. The company is funded by reinvested earnings, EU research grants totalling approximately 30 million PLN across 16 contests, and a PLN 6,000,000 share capital base.

Biofarm firmographics

Firmographics
Name
Biofarm
Legal name
Biofarm Sp. z o.o.
Website
https://biofarm.pl
Company type
Private
Founded year
1988
Operating status
Operating
Headcount range
251–500 employees
Short description
Biofarm is a family-owned Polish pharmaceutical manufacturer producing prescription medicines, OTC drugs, and dietary supplements in neurology, cardiology, psychiatry, and internal medicine. Operating from a single EU GMP-certified facility in Poznań, the company exports to 37 countries across four continents.
Ownership category
akta.pro rank

Biofarm industry classification

Industry
Product category
Generic Pharmaceuticals Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing (3254), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIACAG
Cardiology & Vascular Specialty Pharmaceuticals
SECONDARYHLAIAAAA
Primary Care & General Medicine Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIABAL
Generic Hospital & Institutional Products
SECONDARYCRADAGAG
Weight Management & Metabolic Supplements

Keywords

  • Generic pharmaceuticals
  • Prescription medicines
  • OTC drugs
  • Dietary supplements
  • Contract manufacturing

Where Biofarm is headquartered

Location

Headquarters

HQ city
Poznan
HQ country
Poland
HQ region
Europe

Markets served

Biofarm business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Pharmaceutical product sales (RX prescription medicines): Sales of prescription medicines (RX) covering cardiology, neurology, psychiatry and internal medicine therapeutic areas. Products include Nebicard (nebivolol), Pantopraz (pantoprazol), Metoprolol Biofarm ZK, Biomentin (memantine), Vicebrol (vinpocetine), Atrox (atorvastatin), Artigo (cinnarizine+dimenhydrinate), Aciprex (escitalopram), Asertin (sertraline), Amertil (cetirizine), Sedival, Tamivil, Noctis, Diured, Liprox, Losacor, Losacor HCT, Betanil Forte, Triacyt MR, Pulsaren, Theospirex retard, Proaxon, Aspicam (meloxicam), Lapixen, Tiocolis, Solcidiol, Folifem. Sold through wholesalers and pharmacies in Poland and export markets.
  2. OTC drug sales (over-the-counter): Sales of OTC medicines including Vigalex vitamin D3 (1000, 2000, 4000 IU), Magnefar B6 Forte and Magnefar B6 Bio (magnesium + B6), Biotynox/Biotynox Forte (biotin), Ginkofar line (ginkgo biloba leaf dry extract 40/80/120/240 mg), Tribux Bio (trimebutine), Amertil Bio, Halset, Bioprazol Bio Max. Sold via pharmacy retail channel.
  3. Dietary supplements sales: Sales of dietary supplements including Vigalex D3+K2, Magnefar B6 Cardio, Prewenit Balance D, Prewenit Intensiv B, Neurotynox D, Artrostav Complex D3, Cemax Forte, Cemax, Sinusal Extra. Distributed via pharmacy and retail channels.
  4. Export sales (international): Export of pharmaceutical products to international markets; commenced in 2002. Rosuvastatin was launched in 17 countries in 2022; Tamivil positioned as a leader with over 1 million packages produced in 2025. Biofarm products present in 37 countries on 4 continents as of 2025. Managed by dedicated Export Department (export@biofarm.pl).

Pricing tiers

ModelBillingPrice
OtherAnnualQuote-based B2B pharmaceutical pricing

Go-to-market motion4 records

Biofarm product offering

Product offering

Core offering

Biofarm manufactures and supplies a portfolio of 180+ registered pharmaceutical products across prescription (RX) medicines, over-the-counter (OTC) drugs, dietary supplements, and cosmetics, with ~80% of formulations developed in-house. The portfolio spans cardiology, neurology, psychiatry and internal medicine therapeutic areas and is sold through wholesalers and pharmacies in Poland and exported to 37 countries on four continents, with key innovations including first-in-Poland launches of atorvastatin, OTC omeprazole, memantine, oseltamivir, and vitamin D3 lines.

Product overview

Biofarm Sp. z o.o. operates a single integrated pharmaceutical manufacturing business (no SaaS platform) organized around three core product categories developed and produced at its EU GMP-certified facility in Poznań, Poland: (1) RX (prescription) medicines spanning cardiology, neurology, psychiatry, and internal medicine — including flagship products such as Nebicard (nebivolol), Pantopraz (pantoprazole), Atrox (atorvastatin), Biomentin (memantine), Vicebrol (vinpocetine), Tamivil (oseltamivir), Proaxon (citicoline), Artigo (cinnarizine+dimenhydrinate), Asertin (sertraline), Aciprex (escitalopram), Metoprolol Biofarm ZK (metoprolol succinate), Amertil (cetirizine), and Aspicam (meloxicam); (2) OTC drugs including the memory-support Ginkofar line (40/80/120/240 mg Ginkgo biloba), Bioprazol Bio Max (OTC omeprazole), the Vigalex vitamin D3 line (1000/2000/4000 IU), Magnefar B6 Forte / Magnefar B6 Bio, Biotynox / Biotynox Forte (biotin), Noctis Noc (doxylamine sleep aid), and Trymigan (OTC trimebutine); and (3) dietary supplements such as Vigalex D3+K2, Magnefar B6 Cardio, Prewenit Balance D, Prewenit Intensiv B, Neurotynox D, Artrostav Complex D3, Cemax / Cemax Forte, and Sinusal Extra. Approximately 80% of the portfolio is developed in-house at Biofarm's R&D Centre, and the company holds 13 patent applications covering innovative formulations in oncology, cardiology, psychiatry, and internal medicine. Products are exported to 37 countries across four continents, with key first-in-Poland innovations including Atrox (2007), Bioprazol Bio (2009), Biomentin (2012), Lapixen (2014), Ginkofar Extra (2015), Tribux Bio (2016), Proaxon (2018), Tamivil (2018), Tiocolis (2018), Noctis (2019), Artigo (2019), Nebicard 10 mg (2019), Biotynox Forte (2019), and Solcidiol (2019).

Differentiator

Problem solved

Functional benefit

Brands

  • Ginkofar: OTC/RX line based on Ginkgo biloba extract (40mg, 80mg, 120mg, 240mg doses)
  • Bioprazol Bio
  • Magnefar B6 / Magnefar B6 Forte / Magnefar B6 Cardio
  • Vigalex / Vigalex Forte / Vigalex Max / Vigalex D3+K2
  • Biotynox / Biotynox Forte
  • Sedival
  • Tamivil
  • Diured
  • Proaxon
  • Artigo
  • Noctis
  • Atrox
  • Biomentin
  • Lapixen
  • Tribux Bio
  • Tiocolis
  • Nebicard
  • Solcidiol
  • Pantopraz
  • Metoprolol Biofarm ZK
  • Asertin
  • Aciprex
  • Vicebrol / Vicebrol Forte
  • Amertil / Amertil Bio
  • Aspicam
  • Artigo
  • Cemax / Cemax Forte
  • Prewenit Balance D / Prewenit Intensiv B
  • Neurotynox D
  • Artrostav Complex D3
  • Sinusal Extra

Products and services

  • Atrox (Atorvastatin 10/20/40/80 mg) Atorvastatin tablets (10–80 mg) for hypercholesterolaemia and prevention of cardiovascular events; the first Polish atorvastatin (launched 2007); sold as RX prescription medicine via wholesalers and pharmacies.
  • Biomentin (Memantine 10/20 mg) Memantine hydrochloride tablets (10/20 mg) for moderate-to-severe Alzheimer's disease; the first memantine generic in Europe (launched 2012); sold as RX prescription medicine.
  • Tamivil (Oseltamivir 75 mg) Patented small-tablet oseltamivir formulation (75 mg) for influenza treatment; the first Polish oseltamivir (launched 2018) and a Biofarm production leader with 1M+ packages produced in 2025; sold as RX prescription medicine.
  • Proaxon (Citicoline) Cyticoline-based neurology medicine; the first and only cyticoline-containing medicine in Poland (launched 2018); sold as RX prescription medicine.
  • Nebicard 10 mg (Nebivolol) Nebivolol 10 mg beta-blocker for essential hypertension, chronic stable heart failure, and symptomatic stable coronary artery disease; the first nebivolol 10 mg in Poland (launched 2019); sold as RX prescription medicine.
  • Pantopraz 20/40 mg (Pantoprazole) Pantoprazole 20/40 mg enteric-coated tablets for reflux oesophagitis, H. pylori eradication, gastric/duodenal ulcer, and Zollinger-Ellison syndrome; sold as RX prescription medicine.
  • Vicebrol / Vicebrol Forte (Vinpocetine 5/10 mg) Vinpocetine 5/10 mg tablets for chronic cerebral circulatory insufficiency, vascular dementia, and adjunctive treatment of choroidal/retinal circulatory disorders; sold as RX prescription medicine.
  • Aciprex (Escitalopram 10/20 mg) Escitalopram 10/20 mg SSRI for major depressive episodes, panic disorder, social phobia, OCD, and generalized anxiety disorder; sold as RX prescription medicine.
  • Asertin 50/100 mg (Sertraline) Sertraline 50/100 mg SSRI for major depression, panic disorder, OCD, social anxiety disorder, and PTSD; sold as RX prescription medicine.
  • Metoprolol Biofarm ZK 23.75/47.5 mg Metoprolol succinate extended-release 23.75/47.5 mg for hypertension, angina, cardiac arrhythmias, post-MI prophylaxis, migraine prophylaxis, and stable symptomatic heart failure; sold as RX prescription medicine.
  • Artigo (Cinnarizine 20 mg + Dimenhydrinate 40 mg) Cinnarizine 20 mg + dimenhydrinate 40 mg tablets for treatment of vertigo symptoms of various origins; the first generic of this combination in Poland (launched 2019); sold as RX prescription medicine.
  • Aspicam 15 mg (Meloxicam) Meloxicam 15 mg NSAID for symptomatic treatment of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis; sold as RX prescription medicine.
  • Lapixen (Lacidipine) Lacidipine antihypertensive; the first lacidipine generic drug in Poland (launched 2014); sold as RX prescription medicine.
  • Tiocolis (Thiocolchicoside) Thiocolchicoside muscle relaxant; the first and only thiocolchicoside-based medicine in Poland (launched 2018); sold as RX prescription medicine.
  • Solcidiol (Calcifediol) Calcifediol vitamin D metabolite supplement product; the first calcifediol product in Poland (launched 2019); sold as RX prescription medicine.
  • Sedival (RX) RX medicine in Biofarm's neurology/internal medicine portfolio; sold as RX prescription medicine via wholesalers and pharmacies.
  • Diured (RX) RX diuretic in Biofarm's cardiovascular portfolio; sold as RX prescription medicine.
  • Losacor / Losacor HCT (Losartan ± HCTZ) Losartan and losartan + hydrochlorothiazide combination antihypertensive medicines in Biofarm's RX portfolio; sold as RX prescription medicine.
  • Betanil Forte (RX) RX cardiovascular medicine in Biofarm's RX portfolio; sold as RX prescription medicine.
  • Triacyt MR (RX) Modified-release RX cardiovascular preparation in Biofarm's RX portfolio; sold as RX prescription medicine.
  • Pulsaren 10/20 (RX) RX cardiovascular medicine in Biofarm's RX portfolio; sold as RX prescription medicine.
  • Theospirex retard 150/300 mg Theophylline prolonged-release bronchodilator (150/300 mg); Theospirex retard 300 mg was Biofarm's first drug in production (1991); sold as RX prescription medicine.
  • Amertil (Cetirizine 10 mg) Cetirizine hydrochloride 10 mg antihistamine for seasonal/perennial allergic rhinosinusitis and chronic idiopathic urticaria; sold as RX prescription medicine.
  • Noctis (Doxylamine) Doxylamine-based nighttime sleep-support medicine; the first doxylamine-based product in Poland (launched 2019); sold as RX prescription medicine.
  • Ginkofar (Ginkgo biloba 40/80/120 mg) Ginkgo biloba leaf dry extract tablets (40/80/120 mg) supporting memory and cognitive function; Biofarm's first in-house developed product (1996); sold as OTC drug via pharmacies.
  • Ginkofar Extra (Ginkgo biloba 240 mg) High-dose Ginkgo biloba leaf dry extract 240 mg tablet; the first and only 240 mg Ginkgo Biloba dose in Poland (launched 2015); sold as OTC drug via pharmacies.
  • Bioprazol Bio Max (Omeprazole OTC) OTC omeprazole for gastric reflux; Bioprazol Bio (2009) was the first omeprazole available without prescription in Poland; sold as OTC drug via pharmacies.
  • Vigalex (Vitamin D3 1000/2000/4000 IU line) Vitamin D3 OTC line in 1000/2000/4000 IU dose strengths supporting immunity and bone health; launched in 2020 (Vigalex Bio, Forte, Max) establishing Biofarm as a Vitamin D3 expert; sold as OTC drug via pharmacies.
  • Magnefar B6 Forte / Magnefar B6 Bio Magnesium + Vitamin B6 combinations in higher-dose (Magnefar B6 Forte) and standard (Magnefar B6 Bio) variants for fatigue, cramps and magnesium deficiency symptoms; launched as OTC in 2019; sold via pharmacy retail channel.
  • Biotynox / Biotynox Forte (Biotin 5/10 mg) Biotin (vitamin B7) tablets in 5 mg and 10 mg strengths; Biotynox Forte (2019) was the first drug in Poland with the highest 10 mg biotin dose; sold as OTC drug via pharmacies.
  • Trymigan (OTC Trimebutine) OTC trimebutine product for abdominal/GI symptom relief; Tribux Bio (2016) was the first OTC trimebutine in Europe; sold as OTC drug via pharmacies.
  • Noctis Noc (OTC Sleep Aid) Nighttime sleep-support OTC product based on doxylamine; sold via pharmacy retail channel.
  • Melatonina (OTC) Melatonin-based OTC sleep and circadian rhythm support product; sold via pharmacy retail channel.
  • Amertil Bio (OTC Cetirizine) OTC cetirizine-based antihistamine for allergic rhinitis and chronic idiopathic urticaria; sold via pharmacy retail channel.
  • Soyfem (Soy Isoflavones) Soy isoflavone OTC/supplement for menopausal symptom relief; multiple-time 'Product of the Year' in its category (2005-2011); sold via pharmacy and retail channels.
  • Vigalex D3+K2 (Dietary Supplement) Dietary supplement combining Vitamin D3 with Vitamin K2 to support bone health; distributed via pharmacy and retail channels.
  • Magnefar B6 Cardio (Dietary Supplement) Magnesium + Vitamin B6 dietary supplement positioned for cardiovascular support; distributed via pharmacy and retail channels.
  • Prewenit Balance D (Dietary Supplement) Dietary supplement in Biofarm's Prewenit line supporting micronutrient balance with Vitamin D; distributed via pharmacy and retail channels.
  • Prewenit Intensiv B (Dietary Supplement) Dietary supplement in Biofarm's Prewenit line with intensified B-vitamin composition; distributed via pharmacy and retail channels.
  • Neurotynox D (Dietary Supplement) Dietary supplement combining neurotropic vitamins and Vitamin D for nervous-system support; distributed via pharmacy and retail channels.
  • Artrostav Complex D3 (Dietary Supplement) Joint-and-bone dietary supplement with Vitamin D3; distributed via pharmacy and retail channels.
  • Cemax / Cemax Forte (Vitamin C Dietary Supplements) Vitamin C dietary supplements in regular and Forte dose; distributed via pharmacy and retail channels.
  • Sinusal Extra (Dietary Supplement) Dietary supplement supporting sinus and upper respiratory tract health; distributed via pharmacy and retail channels.
  • Biofarm Cosmetics Line Pharmaceutical-grade cosmetics product line manufactured at the Poznań facility; sold via pharmacy and retail channels.

Companies that use Biofarm

Customer profile

Ideal customer profiles3 records

Biofarm technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Biofarm partnerships and signals

Strategic signal

Recent moves11 records

Expansion highlights6 records

Biofarm competitors and assessment

Company assessment

Direct peers

  • Polpharma: Poland's largest pharmaceutical manufacturer and the most direct domestic peer. Operates a similar generics-plus-OTC model with Rx focus on cardiology, neurology and internal medicine, and exports to CEE/CIS markets — directly overlapping with Biofarm's product, channel and geographic footprint.
  • Adamed Pharma: Polish family-owned pharma company with parallel portfolio strategy: in-house developed generics in cardiology, neurology and psychiatry, plus OTC and dietary supplements, with growing CEE export presence. Closely comparable in therapeutic mix, ownership structure and Polish-CEE GTM motion.
  • KRKA: Slovenian-headquartered generic pharmaceutical manufacturer with a broad Rx portfolio in cardiology, neurology and psychiatry and a multi-continent export footprint including strong CEE/CIS coverage. Comparable in generics-first business model, vertical manufacturing, and emerging-market expansion playbook.
  • Gedeon Richter: Hungarian pharmaceutical company with a generic-heavy portfolio across CNS, cardiology and women's health, plus OTC/supplement extensions, and an export footprint spanning CEE, CIS and Western Europe. Highly comparable therapeutic focus and CEE-centric GTM.
  • Zentiva: European generic and OTC pharmaceutical manufacturer headquartered in Prague with broad pan-European presence. Operates the same generics-plus-OTC-plus-supplement model in cardiology, neurology and internal medicine, with comparable reliance on European reimbursement systems.

Broad incumbents

  • Teva Pharmaceutical Industries: World's largest generic drug manufacturer with a broad generics, specialty and OTC portfolio. Competes with Biofarm across multiple molecules (e.g., memantine, atorvastatin, nebivolol, omeprazole) but at vastly larger scale and global reach.
  • Sandoz: Novartis's generics and biosimilars division; one of the world's largest manufacturers of off-patent medicines including antibiotics, cardiovascular and CNS generics. Competes with Biofarm on global tender pricing across overlapping molecules.
  • Stada Arzneimittel: German generics, specialty and consumer healthcare company with strong European distribution and CEE presence. Overlaps with Biofarm in generics, OTC and dietary supplements, particularly through its Central European footprint.
  • Viatris: Global healthcare company formed from the Mylan-Upjohn merger; offers a broad portfolio of generics, branded and OTC products worldwide, including cardiology and CNS molecules overlapping with Biofarm's Rx portfolio.

Emerging players

  • Alvogen: US-headquartered but with significant Central and Eastern European operations (including Alvogen CEE), focused on generics, biosimilars and OTC across emerging markets. Comparable to Biofarm in CEE export-led generics strategy, though broader in biosimilars.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Biofarm social profiles

Digital presence

Biofarm compliance and trust

Trust signal

Compliance3 records

Biofarm financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Biofarm leadership team

Management profile

Number of profiles

Profiles2 records

Biofarm funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Biofarm M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biofarm

What does Biofarm do?

Biofarm manufactures and supplies a portfolio of 180+ registered pharmaceutical products across prescription (RX) medicines, over-the-counter (OTC) drugs, dietary supplements, and cosmetics, with ~80% of formulations developed in-house. The portfolio spans cardiology, neurology, psychiatry and internal medicine therapeutic areas and is sold through wholesalers and pharmacies in Poland and exported to 37 countries on four continents, with key innovations including first-in-Poland launches of atorvastatin, OTC omeprazole, memantine, oseltamivir, and vitamin D3 lines.

Is Biofarm a public or private company?

Biofarm is a private company. It is classified as family owned and is currently operating.

When was Biofarm founded?

Biofarm was founded in 1988. It employs 251 to 500 people.

Where is Biofarm based?

Biofarm is headquartered in Poznan, Poland, in the Europe region.

How does Biofarm make money?

Four revenue lines are on record. Pharmaceutical product sales (RX prescription medicines) is the primary driver. The others are OTC drug sales (over-the-counter), dietary supplements sales and export sales (international).

Who are Biofarm's main competitors?

Direct peers on record are Polpharma, Adamed Pharma, KRKA, Gedeon Richter and Zentiva. Broad incumbents are Teva Pharmaceutical Industries, Sandoz, Stada Arzneimittel and Viatris. Alvogen is listed as an emerging player.

Does Biofarm have an API?

No public API is recorded for Biofarm.

What industry is Biofarm in?

Biofarm's product category is Generic Pharmaceuticals Manufacturing. Its primary akta.pro industry code is HLAIAAAB, Specialty Care Pharmaceuticals, with a secondary code of HLAIACAG, Cardiology & Vascular Specialty Pharmaceuticals. Its NAICS code is 3254 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales